Since opening its doors, Lung Health Institute has performed over 8,000 cellular therapy procedures, and we’ve treated over 5,900 patients. As part of our patient-centered approach to care and treatment for chronic lung disease, we follow up with all patients for 1 year after their cellular therapy.
Tracking and documenting patient outcomes to measure the effectiveness of our cellular therapy is an important part of our comprehensive care and treatment process. And here at Lung Health Institute, we recognize that an accurate representation of patient results depends on more than raw numbers. We collect both quantitative and qualitative data from our patients. Here, we’ve provided a breakdown of what that means.
The most important set of quantitative data we track is patients’ forced expiratory volume in 1 second (FEV1) score. FEV1 measures how much air a person can forcibly expel from the lungs in 1 second. It’s the most common test used for determining the severity of airway obstruction in people with chronic lung disease. FEV1 is the standard used to classify patients’ GOLD (Global Initiative for Chronic Obstructive Lung Disease) stages.
Last year, Lung Health Institute attended the Mayo Clinic Symposium on Regenerative Medicine & Surgery 2018. We presented the results of a research study that collected patient outcomes from 2,782 chronic lung disease patients who received cellular therapy treatment. Findings showed that 3 months following treatment, 56% of patients had an improvement in their FEV1 scores. This year, our most recent, more-inclusive data set from May 2019 — which included patients with chronic obstructive pulmonary disease (COPD), pulmonary fibrosis (PF) and interstitial lung disease (ILD) — revealed that 3 months following treatment, 51.8% of patients had an improvement in their FEV1 scores.
Before patients receive cellular therapy treatment, they fill out a quality of life survey to document how well they’re able to complete daily activities, exercise and attend social events without experiencing symptoms.
At 3 months following treatment, we have our patients retake the quality of life survey to document how they feel after cellular therapy. We ask patients to assess:
- How well they can perform strenuous activities, like climbing stairs or playing sports
- How well they can perform moderate activities, like walking around the house or completing household chores
- How well they can perform daily activities, like getting dressed or showering
- How well they can perform social activities, like spending time with friends or playing with their grandchildren
We send quality of life surveys again at 6 months and 12 months post treatment. Our data collection has found that 91.6% of patients experience positive patient outcomes at 3 months following cellular therapy.*
Let Lung Health Institute Help You Breathe Easier™
At Lung Health Institute, our work is never done. Our health care team continually pursues new areas of research and analysis of patient outcomes, to ensure that we are providing the most effective treatment possible.
If you are suffering from chronic lung disease, consider cellular therapy. Our treatment is minimally invasive and uses the body’s own healing cells to try and slow the progression of the disease and improve lung function. Our primary goal is to help you Breathe Easier and find meaningful long-term improvements in your quality of life. If you are interested in learning more or scheduling a free consultation, contact one of our patient coordinators today.